Revolution Medicines, Inc. Common Stock (RVMD) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for RVMD. 13F holdings as of 2026-09-30.
In 13F filings for the quarter ended September 30, 2026, 580 institutions reported holding RVMD, with 113.0 million shares worth $23.2 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Vanguard | 19,209,896 | $3.9B | DECREASED |
| FMR | 15,397,714 | $3.2B | INCREASED |
| BlackRock | 13,857,324 | $2.8B | INCREASED |
| Capital Group | 5,462,664 | $1.1B | INCREASED |
| State Street | 5,063,861 | $1.0B | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Alexis Borisy (Director) | GIFT | 10,625 | 2026-11-11 | |
| Jack Anders (Chief Financial Officer) | EXERCISE | 19,850 | $368K | 2026-11-11 |
| Jack Anders (Chief Financial Officer) | EXERCISE | 15,900 | $675K | 2026-11-11 |
| Jack Anders (Chief Financial Officer) | SELL | 9,889 | $2M | 2026-11-11 |
| Jack Anders (Chief Financial Officer) | SELL | 9,486 | $2M | 2026-11-11 |
Full institutional holdings, insider history, and congressional trades for Revolution Medicines, Inc. Common Stock on SentiSense.